Amicus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	543.14	528.3	399.36	329.23	305.51	260.89	Upgrade
Revenue Growth (YoY)	28.25%	32.29%	21.30%	7.76%	17.11%	43.16%	Upgrade
Cost of Revenue	51.07	52.94	37.33	38.6	34.47	31.04	Upgrade
Gross Profit	492.07	475.35	362.03	290.63	271.05	229.84	Upgrade
Selling, General & Admin	327.18	323.38	275.27	213.04	192.71	156.41	Upgrade
Research & Development	108.87	109.36	152.38	276.68	272.05	308.44	Upgrade
Operating Expenses	444.28	441.29	435.52	495.06	470.97	473.7	Upgrade
Operating Income	47.79	34.06	-73.49	-204.43	-199.92	-243.85	Upgrade
Interest Expense	-48.62	-49.6	-50.15	-37.12	-32.47	-22.43	Upgrade
Interest & Investment Income	4.68	5.41	7.08	3.02	0.51	3.23	Upgrade
Other Non Operating Income (Expenses)	-4.48	-9.44	-15.89	4.18	-2.9	-0.78	Upgrade
EBT Excluding Unusual Items	-0.08	-19.57	-132.45	-234.35	-234.78	-263.83	Upgrade
Merger & Restructuring Charges	-3.14	-9.19	-	-	-	-	Upgrade
Asset Writedown	-	-	-1.13	-6.62	-	-	Upgrade
Other Unusual Items	-	-	-16.52	-1.08	-6.77	-10.42	Upgrade
Pretax Income	-3.22	-28.76	-150.1	-242.04	-241.55	-274.25	Upgrade
Income Tax Expense	26.16	27.35	1.48	-5.47	8.91	2.6	Upgrade
Net Income	-29.37	-56.11	-151.58	-236.57	-250.46	-276.85	Upgrade
Net Income to Common	-29.37	-56.11	-151.58	-236.57	-250.46	-276.85	Upgrade
Shares Outstanding (Basic)	306	304	295	289	271	259	Upgrade
Shares Outstanding (Diluted)	306	304	295	289	271	259	Upgrade
Shares Change (YoY)	2.52%	3.12%	2.11%	6.50%	4.85%	7.67%	Upgrade
EPS (Basic)	-0.10	-0.18	-0.51	-0.82	-0.92	-1.07	Upgrade
EPS (Diluted)	-0.10	-0.18	-0.51	-0.82	-0.92	-1.07	Upgrade
Free Cash Flow	1.61	-37.44	-76.53	-170.34	-206.38	-236.52	Upgrade
Free Cash Flow Per Share	0.01	-0.12	-0.26	-0.59	-0.76	-0.91	Upgrade
Gross Margin	90.60%	89.98%	90.65%	88.28%	88.72%	88.10%	Upgrade
Operating Margin	8.80%	6.45%	-18.40%	-62.09%	-65.44%	-93.47%	Upgrade
Profit Margin	-5.41%	-10.62%	-37.96%	-71.85%	-81.98%	-106.12%	Upgrade
Free Cash Flow Margin	0.30%	-7.09%	-19.16%	-51.74%	-67.55%	-90.66%	Upgrade
EBITDA	56.02	42.61	-65.62	-199.08	-193.71	-235.01	Upgrade
EBITDA Margin	10.31%	8.07%	-16.43%	-60.47%	-63.41%	-90.08%	Upgrade
D&A For EBITDA	8.23	8.55	7.87	5.34	6.21	8.85	Upgrade
EBIT	47.79	34.06	-73.49	-204.43	-199.92	-243.85	Upgrade
EBIT Margin	8.80%	6.45%	-18.40%	-62.09%	-65.44%	-93.47%	Upgrade

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q